SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-014299
Filing Date
2023-08-09
Accepted
2023-08-09 16:37:56
Documents
63
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nrbo-20230630x10q.htm   iXBRL 10-Q 1187996
2 EX-31.1 nrbo-20230630xex31d1.htm EX-31.1 17146
3 EX-32.1 nrbo-20230630xex32d1.htm EX-32.1 11052
  Complete submission text file 0001558370-23-014299.txt   5402698

Data Files

Seq Description Document Type Size
4 EX-101.SCH nrbo-20230630.xsd EX-101.SCH 44148
5 EX-101.CAL nrbo-20230630_cal.xml EX-101.CAL 28786
6 EX-101.DEF nrbo-20230630_def.xml EX-101.DEF 168097
7 EX-101.LAB nrbo-20230630_lab.xml EX-101.LAB 356466
8 EX-101.PRE nrbo-20230630_pre.xml EX-101.PRE 266504
57 EXTRACTED XBRL INSTANCE DOCUMENT nrbo-20230630x10q_htm.xml XML 917756
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37809 | Film No.: 231155809
SIC: 2834 Pharmaceutical Preparations